Diabetic nephropathy: newer therapeutic perspectives

Diabetic nephropathy: newer therapeutic perspectives

Diabetic nephropathy (DN is a dreaded consequence of diabetes mellitus, accounting for about 40% of end-stage renal disease (ESRD). It is responsible for significant morbidity and mortality, both directly by causing ESRD and indirectly by increasing cardiovascular risk. Extensive research in this fi...

Full description

Bibliographic Details
Main Authors: Krishna C. Keri, Naga S. Samji, Samuel Blumenthal
Format: Article
Language:English
Published: Greater Baltimore Medical Center 2018-07-01
Series:Journal of Community Hospital Internal Medicine Perspectives
Subjects:
Diabetic nephropathy
SGLT-2 inhibitors
DPP-4 inhibitors
ASK pathway
Online Access:http://dx.doi.org/10.1080/20009666.2018.1500423

Similar Items

Similar Items